Recent studies have indicated that TMEM106B regulates several other neurodegenerative diseases, including PD, Alzheimer’s disease (AD), chronic traumatic encephalopathy (CTE), and limbic-predominant age-related TDP-43 encephalopathy (LATE). Here, TMEM106B is linked to Parkinson disease.